Definition
Maintenance or restoration of immune function is a major goal of treating HIV infection with antiretroviral therapy (ART). Patients who achieve a normal CD4+ T cell count of >500/μL are unlikely to experience opportunistic infections and can expect a near-normal life expectancy, whereas patients whose CD4+ T cell count does not increase above 200/μL have substantially increased long-term mortality. Up to 36 % of patients receiving ART never achieve a normal CD4+ T cell count and immune dysfunction may persist in those that do. Furthermore, immune reconstitution may, paradoxically, result in patients being more susceptible to some immunological disorders. Here, mechanisms of immune reconstitution and the causes, consequences, and management of persistent immune dysfunction and immune reconstitution disorders will be discussed.
Reconstitution of the Immune System Following Suppression of HIV Replication by ART
Depletion of blood CD4+ T cells is the most characteristic immune...
References
Barber DL, et al. Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol. 2012;10:150–6.
Boulware DR, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7:e1000384.
Brenchley JM, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365–71.
Cha L, et al. Interferon-alpha, immune activation and immune dysfunction in treated HIV infection. Clin Trans Immunol. 2014;3:e10.
Chang CC, et al. HIV and co-infections. Immunol Rev. 2013;254:114–42.
Crum NF, et al. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS. 2006;20:466–9.
Estes JD. Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues. Immunol Rev. 2013;254:65–77.
Foulon G, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;38:418–25.
Franco JM, et al. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood. 2002;99:3702–6.
Kelley CF, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48:787–94.
Lederman MM, et al. Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol. 2013;119:51–83.
Meintjes G, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516–23.
Moir S, et al. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9:235–45.
Rajasuriar R, et al. Persistent immune activation in chronic HIV infection: do any interventions work? AIDS. 2013;27:1199–208.
Yanik EL, et al. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis. 2013;57:756–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 © Crown
About this entry
Cite this entry
French, M.A. (2014). Immunological Responses to Antiretroviral Therapy. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_301-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_301-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
HIV-2: Lessons from the Dakar Cohort- Published:
- 01 October 2014
DOI: https://doi.org/10.1007/978-1-4614-9610-6_45-1
-
Original
Immunological Responses to Antiretroviral Therapy- Published:
- 30 September 2014
DOI: https://doi.org/10.1007/978-1-4614-9610-6_301-1